136 related articles for article (PubMed ID: 17116691)
1. STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression.
He Y; Simons SS
Mol Cell Biol; 2007 Feb; 27(4):1467-85. PubMed ID: 17116691
[TBL] [Abstract][Full Text] [Related]
2. Modulation of transcription parameters in glucocorticoid receptor-mediated repression.
Sun Y; Tao YG; Kagan BL; He Y; Simons SS
Mol Cell Endocrinol; 2008 Nov; 295(1-2):59-69. PubMed ID: 18583028
[TBL] [Abstract][Full Text] [Related]
3. Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.
Awasthi S; Simons SS
Mol Cell Endocrinol; 2012 May; 355(1):121-34. PubMed ID: 22342989
[TBL] [Abstract][Full Text] [Related]
4. Nuclear structure-associated TIF2 recruits glucocorticoid receptor and its target DNA.
Ogawa H; Yu RT; Haraguchi T; Hiraoka Y; Nakatani Y; Morohashi K; Umesono K
Biochem Biophys Res Commun; 2004 Jul; 320(1):218-25. PubMed ID: 15207724
[TBL] [Abstract][Full Text] [Related]
5. Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.
Khan SH; Awasthi S; Guo C; Goswami D; Ling J; Griffin PR; Simons SS; Kumar R
J Biol Chem; 2012 Dec; 287(53):44546-60. PubMed ID: 23132854
[TBL] [Abstract][Full Text] [Related]
6. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation.
He Y; Szapary D; Simons SS
J Biol Chem; 2002 Dec; 277(51):49256-66. PubMed ID: 12376547
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.
Wang D; Wang Q; Awasthi S; Simons SS
Biochemistry; 2007 Jul; 46(27):8036-49. PubMed ID: 17571860
[TBL] [Abstract][Full Text] [Related]
8. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
9. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
Tao YG; Xu Y; Xu HE; Simons SS
Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
[TBL] [Abstract][Full Text] [Related]
10. Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.
Li G; Heaton JH; Gelehrter TD
Mol Endocrinol; 2006 May; 20(5):1025-34. PubMed ID: 16423881
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Ttll5/stamp gene (tubulin tyrosine ligase-like protein 5/SRC-1 and TIF2-associated modulatory protein gene) in male mice causes sperm malformation and infertility.
Lee GS; He Y; Dougherty EJ; Jimenez-Movilla M; Avella M; Grullon S; Sharlin DS; Guo C; Blackford JA; Awasthi S; Zhang Z; Armstrong SP; London EC; Chen W; Dean J; Simons SS
J Biol Chem; 2013 May; 288(21):15167-80. PubMed ID: 23558686
[TBL] [Abstract][Full Text] [Related]
12. PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation.
Zhang Z; Sun Y; Cho YW; Chow CC; Simons SS
J Biol Chem; 2013 Jan; 288(1):42-58. PubMed ID: 23161582
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
Szapary D; Huang Y; Simons SS
Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
[TBL] [Abstract][Full Text] [Related]
14. Bag-1M is a component of the in vivo DNA-glucocorticoid receptor complex at hormone-regulated promoter.
Hong W; Baniahmad A; Liu Y; Li H
J Mol Biol; 2008 Dec; 384(1):22-30. PubMed ID: 18822299
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
16. Modulation of glucocorticoid receptor induction properties by cofactors in peripheral blood mononuclear cells.
Luo M; Simons SS
Hum Immunol; 2009 Oct; 70(10):785-9. PubMed ID: 19665040
[TBL] [Abstract][Full Text] [Related]
17. A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity.
Schneikert J; Hübner S; Martin E; Cato AC
J Cell Biol; 1999 Sep; 146(5):929-40. PubMed ID: 10477749
[TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1.
Børud B; Hoang T; Bakke M; Jacob AL; Lund J; Mellgren G
Mol Endocrinol; 2002 Apr; 16(4):757-73. PubMed ID: 11923473
[TBL] [Abstract][Full Text] [Related]
19. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.
Shimizu N; Ouchida R; Yoshikawa N; Hisada T; Watanabe H; Okamoto K; Kusuhara M; Handa H; Morimoto C; Tanaka H
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8555-60. PubMed ID: 15941832
[TBL] [Abstract][Full Text] [Related]
20. STAMP alters the growth of transformed and ovarian cancer cells.
He Y; Blackford JA; Kohn EC; Simons SS
BMC Cancer; 2010 Apr; 10():128. PubMed ID: 20374646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
